Literature DB >> 18455024

Impact of renal failure on liver transplantation survival.

R C Afonso1, R Hidalgo, M P V C Zurstrassen, L E P Fonseca, F L Pandullo, M B Rezende, S P Meira-Filho, B H Ferraz-Neto.   

Abstract

Renal failure after orthotopic liver transplantation (OLT) is a common complication (ranging from 12% to 70%) associated with worse outcomes, particularly when it requires renal replacement therapy (RRT). Renal dysfunction is a common scenario among waiting list patients. It can lead to a worse prognosis after OLT, due to an increased incidence of postoperative renal failure. The aim of this study was to analyze the incidence of renal failure after OLT, its relationship to pretransplant renal dysfunction, and its impact on outcomes. We analyzed data collected prospectively from 152 consecutive OLTs in 139 patients performed by the same team from March 2003 to November 2007. Exclusion criteria for 34 cases included transplantation due to acute liver failure, combined liver-kidney transplantation, retransplantation, and patients who died up to 2 days posttransplantation. Based on creatinine clearance (CCr) calculated at the time of OLT, the 118 patients were classified in two groups: group I, normal pre-OLT renal function (CCr > or = 70 mL/min) versus group II, pre-OLT renal failure (CCr < 70 mL/min). Each group was analyzed according to the development of post-OLT renal failure, being classified as subgroup A (normal renal function post-OLT), subgroup B (mild renal impairment post-OLT-serum creatinine level between 2.0 and 3.0 mg/dL or doubled basal value up to 3.0 mg/dL) versus subgroup C (severe renal impairment post-OLT-serum creatinine level > or = 3.0 mg/dL or utilization of RRT). The overall incidence of post-OLT renal impairment was 41.52% with RRT in 22 patients (18.64%). Group II patients showed a greater incidence of post-OLT renal failure when compared with other patients (P < .05), but without a statistical difference when compared according to RRT requirement. Comparison of average hospital stay was similar between groups I and II, and also among its subgroups (A, B, and C, respectively). There was no statistical difference in early (30-day) and 1-year survival rates between groups I and II. Comparing all subgroups for early and 1-year survival, we observed that patients who developed severe renal failure post-OLT (subgroups I-C and II-C) showed worse outcomes compared with other patients (subgroups I-A, I-B, II-A, and II-B), respectively 95.29% versus 69.69% and 86.95% versus 41.66% for early and 1-year survivals (P < .001). In conclusion, our findings suggested that patients who developed severe renal failure post-OLT, independent of pretransplant renal function, showed worse outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455024     DOI: 10.1016/j.transproceed.2008.02.062

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

1.  The impact of MELD allocation on simultaneous liver-kidney transplantation.

Authors:  Julie A Thompson; John R Lake
Journal:  Curr Gastroenterol Rep       Date:  2009-02

2.  Role of magnetic resonance cholangiography in biliary complications of orthotopic liver transplantation.

Authors:  A Pecchi; M De Santis; F Di Benedetto; M Gibertini; G Gerunda; P Torricelli
Journal:  Radiol Med       Date:  2010-07-31       Impact factor: 3.469

3.  Recent advances in liver transplantation for the practicing gastroenterologist.

Authors:  Ranjan Mascarenhas; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-06

4.  Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience.

Authors:  Pierre Bourgoin; Aicha Merouani; Véronique Phan; Catherine Litalien; Michel Lallier; Fernando Alvarez; Philippe Jouvet
Journal:  Pediatr Nephrol       Date:  2013-12-06       Impact factor: 3.714

5.  Role of proenkephalin in the diagnosis of severe and subclinical acute kidney injury during the perioperative period of liver transplantation.

Authors:  Camila Lima; Daniella Lacerda Gorab; Carol Ribeiro Fernandes; Etienne Macedo
Journal:  Pract Lab Med       Date:  2022-05-06

6.  Kidney function and mortality post-liver transplant in the Model for End-Stage Liver Disease era.

Authors:  Aastha Sethi; Michelle M Estrella; Richard Ugarte; Mohamed G Atta
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-11-03

7.  Dexmedetomidine Pretreatment Attenuates Kidney Injury and Oxidative Stress during Orthotopic Autologous Liver Transplantation in Rats.

Authors:  Xiaofang Yu; Xinjin Chi; Shan Wu; Yi Jin; Hui Yao; Yiheng Wang; Zhengyuan Xia; Jun Cai
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

8.  Impact of preoperative chronic renal failure on liver transplantation: a population-based cohort study.

Authors:  Peter Chi-Ho Chung; Hsiu-Pin Chen; Jr-Rung Lin; Fu-Chao Liu; Huang-Ping Yu
Journal:  Ther Clin Risk Manag       Date:  2016-12-14       Impact factor: 2.423

9.  Early detection of acute kidney injury in the perioperative period of liver transplant with neutrophil gelatinase-associated lipocalin.

Authors:  Camila Lima; Luciana Bertocco de Paiva Haddad; Patrícia Donado Vaz de Melo; Luiz Marcelo Malbouisson; Lilian Pires Freitas do Carmo; Luiz Augusto Carneiro D'Albuquerque; Etienne Macedo
Journal:  BMC Nephrol       Date:  2019-10-15       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.